Kinnos is an infection prevention company transforming patient safety and hospital efficiency.

Kinnos is raising the standard of health by protecting patients, health workers, and the general public from preventable infections.

Kinnos was founded in 2014 by Jason Kang, Katherine Jin, and Kevin Tyan. The company is headquartered in Brooklyn, New York.

Kinnos' goal is to empower healthcare workers and patients to protect themselves and others, eliminate human error during decontamination, and prevent the unnecessary loss of life.

Kinnos' flagship product, Highlight®, is a patented color additive platform that greatly improves disinfection technique and compliance in real-time. Highlight® is used internationally by hospitals, first responders, and humanitarian agencies.


Kinnos is backed Prolog Ventures, Allston Venture Fund, Partnership Fund for New York City, Golden Seeds and others. The company raised $6M in a latest financing on Mar 05, 2020. This brings Kinnos' total funding to $7.8M to date.



  • Year founded: 2014
  • Funding Info: $7.8M over 3 Rounds (Latest Funding Type: Series A)
  • Yearly Revenue: NA
  • Employee Size: 2-10
  • Business Valuation: NA
  • City/Town: Brooklyn
  • State: New York
  • Country: United States
Related businesses